Tehran University of Medical Sciences (TUMS) has announced the third episode of its TUMS EDGE series, dedicated to showcasing the university's cutting-edge research. In this episode, the spotlight is on the Pharmaceutical Nanotechnology Center, recognized as the third-best group in producing Scopus Q1 articles. The Pharmaceutical Nanotechnology group has demonstrated exceptional productivity, publishing an average of 8.6 Scopus Q1 articles per faculty member annually between 2017 and 2021. In this TUMS EDGE episode, Dr. Fatemeh Atyabi, Head of the Pharmaceutical Nanotechnology Department and Professor of Pharmaceutics at the Faculty of Pharmacy, will delve into the factors contributing to the group's remarkable success. TUMS EDGE aims to inspire and highlight the innovative work being conducted at TUMS, fostering a culture of excellence in research and innovation.